MK0966; rofecoxib
Sponsors
Merck Sharp & Dohme LLC
Conditions
PainRheumatoid Arthritis
Phase 3
Phase 4
A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)
TerminatedNCT00140920
Start: 2004-05-25End: 2004-09-27Updated: 2017-05-09
A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)
CompletedNCT00157872
Start: 2004-01-07End: 2004-09-19Target: 150Updated: 2017-05-25